Immunomedics: Annual Report 2013 (Immunomedics) - Mar 22, 2014 - Anticipated patent expiry in US between 2023 and 2024; Anticipated patent expiry in EU between 2023 and 2024; Anticipated patent expiry in Japan between 2023 and 2024
Anticipated patent expiry • Oncology
|